The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Navigating Neurodegeneration: Integrating Biomarkers, Neuroinflammation, and Imaging in Parkinson’s, Alzheimer’s, and Motor Neuron Disorders
Open accessAbstract
Neurodegenerative diseases represent a daunting global challenge, affecting millions worldwide and imposing significant clinical and socioeconomic burdens [...]
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“As a translational biomarker, SV2A PET is well-positioned to monitor antidepressant-induced synaptic restoration [215,216,217,218].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [215]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In Alzheimer’s disease, widespread reductions, particularly in hippocampus and association cortex, correlate with cognitive impairment and track amyloid/tau/neurodegeneration (A/T/N) pathology; similar decreases emerge in Parkinsonian and other neurodegenerative conditions, underscoring presynaptic vulnerability across networks [206,211,213,214,215].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [215]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In Alzheimer’s disease, widespread reductions, particularly in hippocampus and association cortex, correlate with cognitive impairment and track amyloid/tau/neurodegeneration (A/T/N) pathology; similar decreases emerge in Parkinsonian and other neurodegenerative conditions, underscoring presynaptic vulnerability across networks [206,211,213,214,215].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [215]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders · doi:10.1002/mds.26424 · Cited by 7,653
The blood-brain barrier in Alzheimer’s disease
Zenaro, E., Piacentino, G., & Constantin, G. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.007 · Cited by 767
AI in Medical Imaging Informatics: Current Challenges and Future Directions
Panayides, A. S., Amini, A., Filipovic, N. D., Sharma, A., Tsaftaris, S. A., Young, A., Foran, D., Do, N., Golemati, S., Kurc, T., et al. (2020) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2020.2991043 · Cited by 713
Protein misfolding in neurodegenerative diseases: Implications and strategies
Sweeney, P., Park, H., Baumann, M., Dunlop, J., Frydman, J., Kopito, R., McCampbell, A., Leblanc, G., Venkateswaran, A., Nurmi, A., et al. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0077-5 · Cited by 675
Parkinson's disease: Mechanisms, translational models and management strategies
Raza, C., Anjum, R., & Shakeel, N. U. A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.03.057 · Cited by 603
Converging pathways in neurodegeneration, from genetics to mechanisms
Gan, L., Cookson, M. R., Petrucelli, L., & La Spada, A. R. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0237-7 · Cited by 479
Gadhave, D. G., Sugandhi, V. V., Jha, S. K., Nangare, S. N., Gupta, G., Singh, S. K., Dua, K., Cho, H., Hansbro, P. M., & Paudel, K. R. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102357 · Cited by 358
Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia
Ewers, M., Sperling, R. A., Klunk, W. E., Weiner, M. W., & Hampel, H. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.05.005 · Cited by 347
Ding, C., Wu, Y., Chen, X., Chen, Y., Wu, Z., Lin, Z., Kang, D., Fang, W., & Chen, F. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.952161 · Cited by 311
In vitro Models of Neurodegenerative Diseases
Slanzi, A., Iannoto, G., Rossi, B., Zenaro, E., & Constantin, G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00328 · Cited by 290
Cited by
Parkinson’s Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation
Tanaka, M. (2025) · Cells · doi:10.3390/cells14151161 · Cited by 76
Self-citationParkinson’s Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation
Tanaka, M. (2025) · doi:10.20944/preprints202506.2099.v2 · Cited by 57
Self-citationNeuroinflammation and Natural Antidepressants: Balancing Fire with Flora
Godoy, A. C. F., Frota, F. F., Araújo, L. P., Valenti, V. E., Pereira, E. D. S. B. M., Detregiachi, C. R. P., Galhardi, C. M., Caracio, F. C. C., Haber, R. S. A., Laurindo, L. F., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13051129 · Cited by 46
Self-citationFrom Microbial Switches to Metabolic Sensors: Rewiring the Gut–Brain Kynurenine Circuit
Tanaka, M., & Vécsei, L. (2025) · Biomedicines · doi:10.3390/biomedicines13082020 · Cited by 34
Self-citationFrom Microbial Switches to Metabolic Sensors: Rewiring the Gut–Brain Kynurenine Circuit
Tanaka, M., & Vécsei, L. (2025) · doi:10.20944/preprints202506.0880.v1 · Cited by 24
Self-citation
Metadata
- Authors
- Tanaka, M., Battaglia, S., & Liloia, D.
- Affiliations
- University of Szeged (HU)
- University of Turin (IT)
- Corresponding author
- Tanaka, Masaru
- Venue
- Biomedicines
- Publisher
- MDPI AG
- Published
- 2025-04-25
- Volume
- 13
- Issue
- 5
- Pages
- 1045
- ISSN
- 2227-9059 (ISSN-L)
- PMC
- PMC12109388
- OpenAlex
- W4409783063
- Cited by
- 24
- References
- 104
- Citations by year
- 2026: 10 · 2025: 14
- FWCI
- 8.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biomedicines (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- HUN-REN Hungarian Research Network funding (PE0000006, DN. 1553 11.10.2022, 235/22)
- #NEXTGENERATIONEU (PE0000006, DN. 1553 11.10.2022, 235/22)
- Ministry of University and Research (PE0000006, DN. 1553 11.10.2022, 235/22)
- National Recovery and Resilience Plan (PE0000006, DN. 1553 11.10.2022, 235/22)
- Bial Foundation, Portugal (PE0000006, DN. 1553 11.10.2022, 235/22)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- neurodegeneration, biomarkers, neuroinflammation, neuroimaging, Parkinson's disease, Alzheimer's disease, motor neuron disease, neurodegenerative diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Navigating Neurodegeneration: Integrating Biomarkers, Neuroinflammation, and Imaging in Parkinson’s, Alzheimer’s, and Motor Neuron Disorders. https://app.cochat.ai/papers/10.3390/biomedicines13051045
- The paper
- Tanaka, M., Battaglia, S., & Liloia, D. (2025). Navigating Neurodegeneration: Integrating Biomarkers, Neuroinflammation, and Imaging in Parkinson’s, Alzheimer’s, and Motor Neuron Disorders. Biomedicines. https://doi.org/10.3390/biomedicines13051045
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.